Patent 8637478 was granted and assigned to Ionis Pharmaceuticals on January, 2014 by the United States Patent and Trademark Office.
The present invention provides compounds and methods for modulating expression of a protein, including, but not limited to, modulating splicing of a pre-mRNA to modulate the amount of one or more variants of a protein.